Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 10, 2026
Why Is iShares Semiconductor ETF (SOXX) Down -1.15% Today?

Why Is iShares Semiconductor ETF (SOXX) Down -1.15% Today?

Key Takeaways

  • The iShares Semiconductor ETF declined 1.15% on Monday, falling from Friday's close of $543.27 to approximately $537.00 in midday trading.
  • Intel's $15 billion stock offering announcement served as the primary drag, triggering dilution concerns that rippled through the semiconductor sector.
  • Broad-based chip stock weakness compounded the decline, with AMD, Arm Holdings, NXP Semiconductors, and Lam Research all trading in negative territory.
  • Geopolitical and macroeconomic headwinds — including Middle East tensions, elevated Treasury yields near 4.7%, and renewed inflation concerns — weighed on risk appetite.
  • Apple-related news added pressure, as a Jefferies downgrade and reports of Apple's early-stage memory chip negotiations with China's CXMT unsettled the semiconductor supply-chain narrative.
  • Investors are now watching upcoming U.S. CPI and PPI data, NVIDIA's next earnings report, and SanDisk's investor day on August 13 for directional cues.

Opening Summary

The SOXX iShares Semiconductor ETF — which tracks the ICE Semiconductor Index and provides concentrated exposure to 30 leading U.S.-listed semiconductor companies — declined 1.15% on Monday, August 10, 2026. The fund traded around $537.00 in the midday session, down from Friday's closing price of $543.27. The move lower was driven primarily by Intel's surprise announcement of a $15 billion common stock offering, which sent Intel shares down more than 4% and cast a shadow across the broader chip complex. While the decline was moderate by semiconductor-sector standards, it underscored growing investor sensitivity to dilution risk, elevated valuations, and macro uncertainty after a blistering year-to-date rally in chip stocks.

What Drove the ETF Move Today

Intel's $15 Billion Share Sale Shakes Confidence

The dominant catalyst for Monday's semiconductor sell-off was INTC Intel's announcement of a $15 billion underwritten public offering of common stock, with an additional $2.25 billion greenshoe option that could push the total raise to $17.25 billion. Intel stated the proceeds would fund capital expenditures and working capital tied to its foundry ambitions, advanced packaging, and AI compute demand. While management framed the raise as opportunistic — capitalizing on a stock that had nearly tripled year-to-date — the dilution math rattled shareholders. Intel shares tumbled as much as 5%, pulling down the Philadelphia Semiconductor Index by roughly 1% and dragging SOXX along with it. Though traders largely treated the event as an Intel-specific capital-structure story, the sheer size of the offering — representing roughly 3.5% of Intel's market value — was enough to sour sector-wide sentiment.

Broader Chip Weakness and Profit-Taking

Beyond Intel, a broader pullback in semiconductor names compounded SOXX's decline. AMD Advanced Micro Devices fell roughly 1-2%, extending its post-earnings slide, while Arm Holdings dropped more than 4%. NXP Semiconductors, Microchip Technology, and Lam Research each traded more than 1% lower. The Philadelphia Semiconductor Index has now pulled back approximately 15% from its June high, reflecting ongoing profit-taking after a historic rally that saw SOXX gain over 100% year-to-date at its peak. With valuations stretched — AMD trading near 63 times forward earnings against an industry average of 24 — investors are increasingly demanding flawless execution rather than simply rewarding AI exposure.

Macro and Geopolitical Overhang

Macroeconomic conditions further pressured the risk-on trade that had propelled semiconductors higher. The yield on the U.S. 10-year Treasury note surged to approximately 4.7%, reviving concerns that the Federal Reserve could maintain restrictive policy for longer. Persistent tensions between the United States and Iran continued to disrupt key Middle Eastern oil shipping routes, pushing energy prices higher and adding fresh inflation uncertainty. This macro backdrop has driven investors toward defensive sectors and away from high-beta names, and semiconductor ETFs like SOXX — which carries a beta of roughly 2.0 — are especially vulnerable when risk appetite fades.

Apple Supply-Chain Disruption Fears

Reports that Apple has entered early-stage supply negotiations with China's CXMT for memory chips introduced fresh competitive uncertainty into the semiconductor landscape. The Wall Street Journal reported that Apple is testing CXMT components for use in devices sold in China, targeting iPhones and MacBooks. While any formal deal would require White House approval, the prospect of a Chinese memory supplier penetrating Apple's supply chain weighed on shares of incumbent memory leaders Samsung and SK Hynix — and by extension, on the broader semiconductor investment narrative. Separately, Jefferies downgraded Apple stock to "underperform," citing the cancellation of a planned all-glass iPhone that had been expected to boost average selling prices.

Which Holdings Contributed Most

SOXX is a concentrated fund: its top 10 holdings account for approximately 60% of the portfolio, which means individual stock moves can materially influence the ETF's daily performance. The following holdings were among the most significant contributors to Monday's decline:

  • INTC Intel (weight ~5.2%) — Down approximately 4-5% after the $15 billion stock offering announcement. Intel's decline alone accounted for a meaningful share of SOXX's intraday losses.
  • AMD Advanced Micro Devices (weight ~8.5%) — Down roughly 1-2%, continuing a post-earnings drift as investors reassess its premium valuation relative to NVIDIA.
  • NVDA NVIDIA (weight ~8.6%) — Essentially flat to slightly lower. NVIDIA's relative stability prevented a steeper decline in the ETF.
  • AVGO Broadcom (weight ~7.5%) — Near flat, providing ballast against the Intel-driven weakness.
  • MU Micron Technology (weight ~8.3%) — Modestly lower, with memory-chip sentiment dampened by the Apple-CXMT supply-chain headlines.

Market Context and Trading Activity

Monday's decline in SOXX aligned closely with the Philadelphia Semiconductor Index, which also fell roughly 1%. Broader equity indices were mixed: the Dow Jones Industrial Average, Nasdaq Composite, and S&P 500 oscillated between small gains and losses, reflecting a market in wait-and-see mode ahead of this week's critical inflation data. The CBOE Volatility Index (VIX) remained elevated relative to its summer lows, signaling lingering investor caution. Trading volume in semiconductor names appeared above average, consistent with the news-driven nature of the Intel offering. Importantly, the decline did not breach any major technical support levels for SOXX, suggesting the move was more a reflection of single-stock shock and macro caution than a wholesale sector rotation.

What Comes Next for SOXX

Looking ahead, several catalysts will determine whether SOXX can regain its footing. This week's U.S. Consumer Price Index (CPI) and Producer Price Index (PPI) reports will heavily influence interest-rate expectations and, by extension, appetite for growth-sensitive semiconductor stocks. SanDisk's investor day on August 13 could reset sentiment around the memory cycle, particularly regarding long-term contract visibility and pricing power. NVIDIA's upcoming earnings report remains the marquee event for the AI-chip narrative, with investors eager to see whether data-center demand continues to exceed supply. On the geopolitical front, any de-escalation in U.S.-Iran tensions could ease oil prices and lift risk appetite.

Risks remain tilted to the downside in the near term. The semiconductor sector's valuation reset is still underway, and further profit-taking is possible if economic data surprises to the upside and reinforces the higher-for-longer rate narrative. Additionally, Intel's capital raise may not be the last — if other chipmakers follow suit to fund expensive fab expansions, dilution fears could broaden. That said, the structural demand story remains intact: global semiconductor sales surged 33.1% quarter-over-quarter in Q2 2026, and AI infrastructure spending continues to accelerate. SOXX remains one of the most direct vehicles for investors seeking concentrated exposure to that long-term trend, but elevated volatility should be expected along the way.

Trending AI Robots

For investors seeking to navigate volatile sectors like semiconductors with a data-driven approach, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron provides hundreds of AI trading bots covering thousands of tickers across multiple strategies, timeframes, and performance metrics. Only the strongest performers under current market conditions are featured in the Trending AI Robots section, making it a practical starting point for traders who want to combine algorithmic precision with human oversight. Explore the Trending AI Robots to see which strategies are resonating in today's market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SOXX

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


SOXX's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for SOXX moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In of the 21 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on SOXX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SOXX just turned positive on August 05, 2026. Looking at past instances where SOXX's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SOXX advanced for three days, in of 352 cases, the price rose further within the following month. The odds of a continued upward trend are .

SOXX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

SOXX moved below its 50-day moving average on July 15, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SOXX crossed bearishly below the 50-day moving average on July 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOXX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SOXX entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Broadcom Inc. (NASDAQ:AVGO), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), Texas Instruments (NASDAQ:TXN), KLA Corporation (NASDAQ:KLAC).

Industry description

The investment seeks to track the investment results of the NYSE Semiconductor Index composed of U.S. equities in the semiconductor sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.

Market Cap

The average market capitalization across the iShares Semiconductor ETF ETF is 451.33B. The market cap for tickers in the group ranges from 4.19B to 5.42T. NVDA holds the highest valuation in this group at 5.42T. The lowest valued company is OLED at 4.19B.

High and low price notable news

The average weekly price growth across all stocks in the iShares Semiconductor ETF ETF was 20%. For the same ETF, the average monthly price growth was 14%, and the average quarterly price growth was 157%. ENTG experienced the highest price growth at 28%, while MPWR experienced the biggest fall at -2%.

Volume

The average weekly volume growth across all stocks in the iShares Semiconductor ETF ETF was -23%. For the same stocks of the ETF, the average monthly volume growth was -22% and the average quarterly volume growth was -65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 65
P/E Growth Rating: 32
Price Growth Rating: 39
SMR Rating: 54
Profit Risk Rating: 49
Seasonality Score: -43 (-100 ... +100)
View a ticker or compare two or three
SOXX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Technology

Profile
Details
Category
Technology
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.